We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > disease

News List

Second Phase 3 Study Results for LMTX® Published in the Journal of Alzheimer's Disease prnasia
November 27, 2017
TauRx Therapeutics Ltd today reported the full results from its second Phase 3 clinical study of LMTX®, the first tau aggregation inhibitor in Alzheimer's disease, published online in the Journal of Alzheimer's Disease.
New Gates Foundation Report Highlights Remarkable Progress Against Global Poverty and Disease, Warns September 13, 2017
The Bill & Melinda Gates Foundation today launched an inaugural annual report showcasing the remarkable progress that has been made in reducing extreme poverty and disease in recent decades
Ocalvia gets NHS green light for rare chronic liver disease pharmatimes
April 28, 2017
Intercept's Ocaliva has been issued a final green light for use by the NHS to treat the rare chronic liver disease primary ...
RGC, UK Biobank and GSK launch new initiative to improve disease diagnosis pharmaceutical-technology
March 27, 2017
Regeneron Genetics Center (RGC), UK Biobank and GSK have launched a gene sequencing initiative on the world's detailed health database.